ZTS today
$82.72+$0.16 (+0.19%)close Nov 12, 2026Trend
DailyUptrend (confirmed)
4 hourStrong Bullish
1 hourAscending Triangle
15 minBearish
5 minBullish
Daily trend turns down below $77.03
Key levels
Resistance$112.97
Resistance$89.28
Support$82.29
Support$78.63
Latest news & SEC filings
ProductUSDA grants Zoetis approval for Cytopoint Plus
AnalystJefferies raises Zoetis price target to $85 from $83
NewsRepublican Senator Sells Magnificent Seven Stocks After Reelection Win
All ZTS news →About Zoetis
Zoetis is an animal health company that develops, makes, and sells medicines, vaccines, diagnostic tests, and related offerings for pets and farm animals. Its products cover eight main species and include parasite treatments, skin condition therapies, pain relief, and infection-fighting drugs, plus breeding tools, data-driven services, and monitoring technologies. Buyers include veterinary practices, ranchers and farmers, and pet owners, and the company operates in more than 100 countries via direct sales, distributors, stores, and online sellers.
Based on the company's 10-K filed Feb 12, 2026.
NYSE · Healthcare
Zoetis Inc. (ZTS)
What Is the Price Target for ZTS?
SEPT Low Target
$74.00
SEPT Mid Target
$85.00
SEPT High Target
$115.00
Analyst Consensus
$85.00
Is ZTS a Buy or Sell Right Now?
Thesis
- •Revenue growing 2.3% YoY with STABLE trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ZTS.
Start Free Trial →Is ZTS Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$74.21
44
Moat Score
NARROW
5/9
Piotroski Score
4.2
Altman Z-Score
What Is Smart Money Doing with ZTS?
Insider Signal
NEUTRAL
3 buys / 0 sells (90d)
Congress Signal
BUYING
8 buys / 6 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| DAMELIO FRANK A | director | Sale | 6,650 | - | Aug 7, 2026 |
| MCCALLISTER MICHAEL B | director | Sale | 1,209 | - | Jun 10, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ZTS Growth Story
Revenue YoY
2.3%
3yr Revenue CAGR
5.4%
EPS Growth YoY
10.05%
FCF Growth YoY
-0.7%
Revenue Trend
STABLE
Dark Pool Trades for ZTS
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ZTS, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 16:10:19 | $82.72 | 1,462 | $$121K | SELL |
| 16:10:07 | $82.78 | 1,143 | $$95K | MIDPOINT |
| 15:52:10 | $83.20 | 1,383 | $$115K | SELL |
| 15:48:42 | $83.37 | 1,434 | $$120K | BUY |
| 15:31:11 | $83.40 | 1,177 | $$98K | BUY |
5 dark pool trades shown · $$548K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for ZTS
PREVIEWSEPT Investing provides real-time options flow tracking for ZTS, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $65 | Dec 18 | 36 | $$50 | 5 | SWEEP |
| CALL | $85 | Nov 20 | 8 | $$420 | 4 | SWEEP |
| CALL | $85 | Nov 20 | 8 | $$210 | 2 | SWEEP |
| CALL | $85 | Nov 20 | 8 | $$105 | 1 | SWEEP |
| CALL | $85 | Nov 20 | 8 | $$1050 | 10 | SWEEP |
5 options trades shown · 80% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Zoetis Inc. (ZTS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (12 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ZTS — frequently asked questions
What is ZTS stock price today?
Zoetis Inc. (ZTS) is at $82.72, up 0.19% (+$0.16) at the Nov 12, 2026 close.
Why is ZTS stock moving today?
Latest ZTS news — Nov 11, 2026: USDA grants Zoetis approval for Cytopoint Plus · Nov 6, 2026: Jefferies raises Zoetis price target to $85 from $83
Why did ZTS stock move on Nov 5, 2026?
Zoetis reported Q3 2026 results and cut its full-year GAAP EPS guidance to $5.50-$5.60 from $5.55-$5.65, with the new midpoint below the $5.76 analyst estimate. The company also projected high single-digit revenue declines in Q3 and Q4, citing softer pet spending, a 5% drop in canine vet visits, and a 3% decline in U.S.
What is the ZTS price target?
The average analyst price target for ZTS is $85.00, ranging from $74 to $115, based on 11 analysts. Latest: Morgan Stanley maintains on Oct 29, 2026.
What do analysts rate ZTS?
Analyst ratings for ZTS: 1 Buy, 26 Hold, 0 Sell — consensus Hold.
Did ZTS beat earnings?
ZTS last reported on Nov 5, 2026: EPS $1.75 vs $1.51 expected — a beat of 15.9%.
What is ZTS's P/E ratio?
ZTS trades at a P/E of 13.4 vs a Healthcare average of 17.7.
Does ZTS pay a dividend?
Yes. ZTS's dividend yield is 1.59%.
What are ZTS support and resistance levels?
Support: $82.29, $78.63, $74.25. Resistance: $89.28, $112.97, $116.25.
What are insiders doing with ZTS?
Insider activity: NEUTRAL, 3 buys and 0 sells in the last 90 days.
What is the latest news on ZTS?
Nov 11, 2026: USDA grants Zoetis approval for Cytopoint Plus · Nov 6, 2026: Jefferies raises Zoetis price target to $85 from $83 · Nov 5, 2026: Republican Senator Sells Magnificent Seven Stocks After Reelection Win